Lisa A Uebelacker1, Lauren M Weinstock2, Cynthia L Battle2, Ana M Abrantes2, Ivan W Miller2. 1. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI 02906, USA; Butler Hospital, 345 Blackstone Boulevard, Providence, RI 02906, USA. Electronic address: Luebelacker@butler.org. 2. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI 02906, USA; Butler Hospital, 345 Blackstone Boulevard, Providence, RI 02906, USA.
Abstract
BACKGROUND: Hatha yoga may be helpful for alleviating depression symptoms. The purpose of this analysis is to determine whether treatment program preference, credibility, or expectancy predict engagement in depression interventions (yoga or a control class) or depression symptom severity over time. METHODS: This is a secondary analysis of a randomized controlled trial (RCT) of hatha yoga vs. a health education control group for treatment of depression. Depressed participants (n = 122) attended up to 20 classes over a period of 10 weeks, and then completed additional assessments after 3 and 6 months. We assessed treatment preference prior to randomization, and treatment credibility and expectancy after participants attended their first class. Treatment "concordance" indicated that treatment preference matched assigned treatment. RESULTS:Treatment credibility, expectancy, and concordance were not associated with treatment engagement. Treatment expectancy moderated the association between treatment group and depression. Depression severity over time differed by expectancy level for the yoga group but not for the health education group. Controlling for baseline depression, participants in the yoga group with an average or high expectancy for improvement showed lower depression symptoms across the acute intervention and follow-up period than those with a low expectancy for improvement. There was a trend for a similar pattern for credibility. Concordance was not associated with treatment outcome. LIMITATIONS: This is a secondary, post-hoc analysis and should be considered hypothesis-generating. CONCLUSIONS: Results suggest that expectancy improves the likelihood of success only for a intervention thought to actively target depression (yoga) and not a control intervention.
RCT Entities:
BACKGROUND: Hatha yoga may be helpful for alleviating depression symptoms. The purpose of this analysis is to determine whether treatment program preference, credibility, or expectancy predict engagement in depression interventions (yoga or a control class) or depression symptom severity over time. METHODS: This is a secondary analysis of a randomized controlled trial (RCT) of hatha yoga vs. a health education control group for treatment of depression. Depressedparticipants (n = 122) attended up to 20 classes over a period of 10 weeks, and then completed additional assessments after 3 and 6 months. We assessed treatment preference prior to randomization, and treatment credibility and expectancy after participants attended their first class. Treatment "concordance" indicated that treatment preference matched assigned treatment. RESULTS: Treatment credibility, expectancy, and concordance were not associated with treatment engagement. Treatment expectancy moderated the association between treatment group and depression. Depression severity over time differed by expectancy level for the yoga group but not for the health education group. Controlling for baseline depression, participants in the yoga group with an average or high expectancy for improvement showed lower depression symptoms across the acute intervention and follow-up period than those with a low expectancy for improvement. There was a trend for a similar pattern for credibility. Concordance was not associated with treatment outcome. LIMITATIONS: This is a secondary, post-hoc analysis and should be considered hypothesis-generating. CONCLUSIONS: Results suggest that expectancy improves the likelihood of success only for a intervention thought to actively target depression (yoga) and not a control intervention.
Authors: Lisa A Uebelacker; Morganne Kraines; Monica K Broughton; Geoffrey Tremont; L Tom Gillette; Gary Epstein-Lubow; Ana M Abrantes; Cynthia Battle; Ivan W Miller Journal: Complement Ther Med Date: 2017-06-27 Impact factor: 2.446
Authors: L A Uebelacker; G Tremont; L T Gillette; G Epstein-Lubow; D R Strong; A M Abrantes; A R Tyrka; T Tran; B A Gaudiano; I W Miller Journal: Psychol Med Date: 2017-04-06 Impact factor: 7.723
Authors: Tessa Katherine Mooney; Mary Beth Connolly Gibbons; Robert Gallop; Rachel A Mack; Paul Crits-Christoph Journal: Psychother Res Date: 2013-11-13
Authors: A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller Journal: Biol Psychiatry Date: 2003-09-01 Impact factor: 13.382
Authors: Samir El Alaoui; Brjánn Ljótsson; Erik Hedman; Viktor Kaldo; Evelyn Andersson; Christian Rück; Gerhard Andersson; Nils Lindefors Journal: PLoS One Date: 2015-04-20 Impact factor: 3.240
Authors: Jana Sommer; Jan Dyczmons; Sandra Grobosch; Veronika Gontscharuk; Markus Vomhof; Michael Roden; Andrea Icks Journal: BMJ Open Date: 2020-09-09 Impact factor: 2.692
Authors: W Iris Zhi; Raymond E Baser; Lillian M Zhi; Dristi Talukder; Qing S Li; Tina Paul; Clare Patterson; Lauren Piulson; Christina Seluzicki; Mary L Galantino; Ting Bao Journal: Cancer Med Date: 2021-07-02 Impact factor: 4.452